Kiora Pharmaceuticals earnings were -$12.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest KPRX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$2.2M, down 48.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, KPRX reported annual earnings of $3.6M, with -127.6% growth.
Kiora Pharmaceuticals Earnings Reports & History FAQ
What were Kiora Pharmaceuticals's earnings last quarter?
On KPRX's earnings call on Invalid Date, Kiora Pharmaceuticals (NASDAQ: KPRX) reported Q1 2025 earnings per share (EPS) of -$0.52, up 111.13% year over year. Total KPRX earnings for the quarter were -$2.19 million. In the same quarter last year, Kiora Pharmaceuticals's earnings per share (EPS) was $4.67.
Is Kiora Pharmaceuticals profitable or losing money?
As of the last Kiora Pharmaceuticals earnings report, Kiora Pharmaceuticals is currently losing money. Kiora Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$12.05 million, a 529.21% decrease year over year.
What was KPRX's earnings growth in the past year?
As of Kiora Pharmaceuticals's earnings date in Invalid Date, Kiora Pharmaceuticals's earnings has grown year over year. KPRX earnings in the past year totalled -$12.05 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.